As drugmakers race to understand how effective current COVID-19 vaccines may be against the new Omicron variant, Novavax has announced it anticipates the ability to begin mass manufacturing an Omicron-specific vaccine as soon as January next year.

Source of Article

A new study has drilled into the relationship between the timing of our meals and the body's blood glucose levels, finding that those chowing down after dark may be at greater risk of diabetes and obesity.

Source of Article

Two new reports out of South Africa are offering some early insights into how the Omicron variant could behave in humans. One report speculates the disease may be milder than prior variants, while another indicates Omicron may lead to more reinfections.

Source of Article